Esophagus |
|
|
Clinical Trial: Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
This study is no longer recruiting patients.
Purpose
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic or recurrent cancer of the esophagus.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| stage IV gastric cancer recurrent gastric cancer stage IV esophageal cancer recurrent esophageal cancer adenocarcinoma of the stomach squamous cell carcinoma of the esophagus Adenocarcinoma of the Esophagus | Drug: gemcitabine Drug: irinotecan Procedure: chemotherapy | Phase II |
MedlinePlus related topics: Esophageal Cancer; Stomach Cancer
Study Type: Interventional
Study Design: Treatment
Official Title: Phase II Study of Gemcitabine and Irinotecan in Patients With Metastatic or Recurrent Carcinoma of the Esophagus or Gastroesophageal Junction
OBJECTIVES:
- Determine the 6-month survival rate of patients with metastatic or recurrent carcinoma of the esophagus or gastroesophageal junction treated with gemcitabine and irinotecan.
- Determine the qualitative and quantitative toxic effects of this regimen in these patients.
OUTLINE: Patients receive gemcitabine IV over 30 minutes and irinotecan IV over 90 minutes on days 1 and 8. Treatment repeats every 21 days for at least 6 courses in the absence of disease progression or unacceptable toxicity.
Patients are followed every 3 months for 1 year and then every 6 months for 2 years.
PROJECTED ACCRUAL: A total of 30-55 patients will be accrued for this study.
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Histologically confirmed metastatic or recurrent carcinoma of the esophagus or gastroesophageal junction
- Squamous cell carcinoma OR
- Adenocarcinoma
- No known brain metastases
PATIENT CHARACTERISTICS: Age:
- 18 to 100
Performance status:
- Zubrod 0-2
Life expectancy:
- Not specified
Hematopoietic:
- Granulocyte count at least 1,500/mm^3
- Platelet count at least 100,000/mm^3
Hepatic:
- Not specified
Renal:
- Creatinine no greater than 1.5 times upper limit of normal
Cardiovascular:
- No uncontrolled hypertension
- No unstable angina
- No symptomatic congestive heart failure
- No myocardial infarction within the past 6 months
- No serious uncontrolled cardiac arrhythmia
Gastrointestinal:
- No active inflammatory bowel disease
- No significant bowel obstruction
- No chronic diarrhea
Other:
- Not pregnant or nursing
- Fertile patients must use effective contraception
- No active infection requiring systemic therapy
- No other prior malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or adequately treated stage I or II cancer in complete remission
PRIOR CONCURRENT THERAPY: Biologic therapy:
- At least 28 days since prior biologic therapy
- No prior biologic therapy for metastatic or recurrent disease
- No concurrent sargramostim (GM-CSF)
- No concurrent immunotherapy for tumor
Chemotherapy:
- At least 28 days since prior chemotherapy
- No prior chemotherapy for metastatic or recurrent disease
- No prior gemcitabine or irinotecan
- Prior adjuvant or neoadjuvant chemotherapy at time of initial diagnosis of localized disease allowed
- No other concurrent chemotherapy for tumor
Endocrine therapy:
- See Disease Characteristics
- At least 28 days since prior endocrine therapy
- No prior endocrine therapy for metastatic or recurrent disease
- No concurrent hormonal therapy for tumor
Radiotherapy:
- At least 28 days since prior radiotherapy
- No prior radiotherapy for metastatic or recurrent disease
- Prior adjuvant or neoadjuvant radiotherapy at time of initial diagnosis of localized disease allowed
- No concurrent radiotherapy for tumor
Surgery:
Other:
- No other concurrent anti-cancer therapy for tumor
Location Information
Alabama
MBCCOP - Gulf Coast, Mobile, Alabama, 36688, United States
Arizona
Arizona Cancer Center, Tucson, Arizona, 85724, United States
CCOP - Greater Phoenix, Phoenix, Arizona, 85006-2726, United States
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden), Phoenix, Arizona, 85012, United States
Veterans Affairs Medical Center - Tucson, Tucson, Arizona, 85723, United States
Arkansas
University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States
Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, 72205, United States
California
CCOP - Bay Area Tumor Institute, Oakland, California, 94609-3305, United States
CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, 95403, United States
Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States
City of Hope Comprehensive Cancer Center, Duarte, California, 91010, United States
David Grant Medical Center, Travis Air Force Base, California, 94535, United States
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, 90095-1781, United States
University of California Davis Medical Center, Sacramento, California, 95817, United States
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, 90033-0804, United States
Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, 90073, United States
Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, 94553, United States
Colorado
University of Colorado Cancer Center, Denver, Colorado, 80010, United States
Veterans Affairs Medical Center - Denver, Denver, Colorado, 80220, United States
District of Columbia
MBCCOP-Howard University Cancer Center, Washington, District of Columbia, 20060, United States
Georgia
CCOP - Atlanta Regional, Atlanta, Georgia, 30342-1701, United States
Dwight David Eisenhower Army Medical Center, Fort Gordon, Georgia, 30905-5650, United States
Hawaii
Cancer Research Center of Hawaii, Honolulu, Hawaii, 96813-2424, United States
Tripler Army Medical Center, Honolulu, Hawaii, 96859-5000, United States
Illinois
CCOP - Central Illinois, Decatur, Illinois, 62526, United States
Loyola University Medical Center, Maywood, Illinois, 60153, United States
MBCCOP - University of Illinois at Chicago, Chicago, Illinois, 60612-7323, United States
Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, 60612, United States
Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines, Illinois, 60141, United States
Kansas
CCOP - Wichita, Wichita, Kansas, 67214-3882, United States
University of Kansas Medical Center, Kansas City, Kansas, 66160-7353, United States
Veterans Affairs Medical Center - Wichita, Wichita, Kansas, 67218, United States
Kentucky
Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky, 40536-0084, United States
Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, 40502-2236, United States
Louisiana
Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, 71130-3932, United States
MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, 70112, United States
Tulane University School of Medicine, New Orleans, Louisiana, 70112, United States
Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, 71130, United States
Massachusetts
Boston Medical Center, Boston, Massachusetts, 02118, United States
Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts, 02130, United States
Michigan
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201-1379, United States
CCOP - Ann Arbor Regional, Ann Arbor, Michigan, 48106, United States
CCOP - Beaumont, Royal Oak, Michigan, 48073-6769, United States
CCOP - Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, 49503, United States
Henry Ford Hospital, Detroit, Michigan, 48202, United States
Providence Hospital - Southfield, Southfield, Michigan, 48075-9975, United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109-0912, United States
Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan, 48105, United States
Veterans Affairs Medical Center - Detroit, Detroit, Michigan, 48201-1932, United States
Minnesota
CCOP - Duluth, Duluth, Minnesota, 55805, United States
Mississippi
Keesler Medical Center - Keesler AFB, Keesler AFB, Mississippi, 39534-2576, United States
University of Mississippi Medical Center, Jackson, Mississippi, 39216-4505, United States
Veterans Affairs Medical Center - Biloxi, Biloxi, Mississippi, 39531-2410, United States
Veterans Affairs Medical Center - Jackson, Jackson, Mississippi, 39216, United States
Missouri
CCOP - Cancer Research for the Ozarks, Springfield, Missouri, 65807, United States
CCOP - Kansas City, Kansas City, Missouri, 64131, United States
CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, 63141, United States
St. Louis University Health Sciences Center, Saint Louis, Missouri, 63110, United States
Veterans Affairs Medical Center - Kansas City, Kansas City, Missouri, 64128, United States
Montana
CCOP - Montana Cancer Consortium, Billings, Montana, 59101, United States
New Mexico
MBCCOP - University of New Mexico HSC, Albuquerque, New Mexico, 87131, United States
Veterans Affairs Medical Center - Albuquerque, Albuquerque, New Mexico, 87108-5138, United States
New York
Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States
University of Rochester Medical Center, Rochester, New York, 14642, United States
Veterans Affairs Medical Center - Albany, Albany, New York, 12208, United States
North Carolina
CCOP - Southeast Cancer Control Consortium, Winston Salem, North Carolina, 27104-4241, United States
Ohio
Barrett Cancer Center, The University Hospital, Cincinnati, Ohio, 45267-0501, United States
CCOP - Columbus, Columbus, Ohio, 43206, United States
CCOP - Dayton, Kettering, Ohio, 45429, United States
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195-9001, United States
Veterans Affairs Medical Center - Cincinnati, Cincinnati, Ohio, 45220-2288, United States
Veterans Affairs Medical Center - Dayton, Dayton, Ohio, 45428, United States
Oklahoma
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, 73104, United States
Veterans Affairs Medical Center - Oklahoma City, Oklahoma City, Oklahoma, 73104, United States
Oregon
CCOP - Columbia River Program, Portland, Oregon, 97225, United States
OHSU Cancer Institute, Portland, Oregon, 97239, United States
Veterans Affairs Medical Center - Portland, Portland, Oregon, 97207, United States
South Carolina
CCOP - Greenville, Greenville, South Carolina, 29615, United States
CCOP - Upstate Carolina, Spartanburg, South Carolina, 29303, United States
Medical University of South Carolina, Charleston, South Carolina, 29425-0721, United States
Veterans Affairs Medical Center - Charleston, Charleston, South Carolina, 29401-5799, United States
Texas
Brooke Army Medical Center, Fort Sam Houston, Texas, 78234-6200, United States
CCOP - Scott and White Hospital, Temple, Texas, 76508, United States
University of Texas - MD Anderson Cancer Center, Houston, Texas, 77030-4095, United States
University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78284-7845, United States
University of Texas Medical Branch, Galveston, Texas, 77555-0565, United States
Veterans Affairs Medical Center - Houston, Houston, Texas, 77030, United States
Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, 78284, United States
Veterans Affairs Medical Center - Temple, Temple, Texas, 76504, United States
Utah
Huntsman Cancer Institute, Salt Lake City, Utah, 84112-5550, United States
Veterans Affairs Medical Center - Salt Lake City, Salt Lake City, Utah, 84148, United States
Washington
CCOP - Northwest, Tacoma, Washington, 98405-0986, United States
CCOP - Virginia Mason Research Center, Seattle, Washington, 98101, United States
Madigan Army Medical Center, Tacoma, Washington, 98431-5000, United States
Swedish Cancer Institute, Seattle, Washington, 98104, United States
Veterans Affairs Medical Center - Seattle, Seattle, Washington, 98108, United States
Stephen K. Williamson, MD, Study Chair, University of Kansas
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: March 2003
Last Updated: October 13, 2004
Record first received: March 3, 2001
ClinicalTrials.gov Identifier: NCT00012363
Health Authority: Unspecified
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Esophagus (National Institute of Diabetes and Digestive and Kidney Diseases)

Not Signed In -


